Dr. Mick Peterson, executive director of the Racing Surfaces Testing Laboratory, was on hand at Keeneland the weekend of Oct. 10-11 to review testing and measuring procedures to ensure the safety of the dirt track.
Keeneland said Oct. 8 it officially is in support of the Thoroughbred Horseracing Integrity Act of 2015 and has joined the Coalition for Horse Racing Integrity, a group that also supports the federal legislation.
The Kentucky Horse Racing Commission has suspended Graham Motion for five days and fined the trainer $500 for a medication overage in Bewitch Stakes (gr. IIIT) winner Kitten's Point. Motion has appealed the ruling.
The New York State Gaming Commission Sept. 24 passed several rule amendments related to equine medication, including further restrictions on the use of non-steroidal anti-inflammatory drugs and a total ban on stanozolol.
In a survey designed to combat claims that the leaders of horsemen's groups don't represent their membership, the Florida HBPA Sept. 16 released the results of a poll that said most respondents support use of Lasix.
Nearly a month after the California Horse Racing Board hit the brakes on third-party administration of furosemide in the state, the governing body spent just more than a minute to move the process along at a meeting Sept. 16.
Two research projects designed to study the impact of furosemide on exercise-induced pulmonary hemorrhage will be conducted on behalf of the Grayson-Jockey Club Research Foundation, the organization said Sept. 15.
The United States Anti-Doping Agency assisted the Drug Enforcement Agency in a nationwide series of enforcement actions targeting the global underground trade of anabolic steroids and other performance-enhancing drugs.
With the year's first major yearling sales in the book and the marathon September sale at Keeneland on the horizon, buyers will be working on where to take the next steps with their purchases.
The Indiana Horse Racing Commission said Aug. 31 that none of the 221 samples tested for cobalt during the first 60 days of the Indiana Grand Racing & Casino meet were above the published threshold level.
The New York Thoroughbred Horsemen's Association Sept. 1 said it will commit $450,000 to acquire state-of-the-art equipment for the New York Equine Drug Testing and Research Program at Morrisville State College.
The California Thoroughbred Trainers Aug. 31 said its leadership unanimously agreed to use $150,000 from reserve funds to facilitate race-day camera surveillance in barn areas at California racetracks.
A new study funded by the USTA is designed to determine whether the naturally occurring mineral cobalt, when administered in larger, regular doses, has blood-doping qualities and could enhance performance.
Medication matters dominated the Aug. 18 meeting of the Kentucky Horse Racing Commission, which voted to change the descriptions for the drug classification schedules that are used to determine if a violation has occurred.
A co-sponsor of federal legislation that would authorize oversight of equine medication and drug-testing said Congress could schedule a committee hearing on the bill this fall. Meanwhile, the debate on the bill continues.
The opening panel Aug. 11 at the Saratoga Institute on Racing, Equine, and Gaming Law conference set the tone for what figures to be a continued industry battle over federal versus state-by-state regulation.
The Jockey Club Thoroughbred Safety Committee will implement a centralized database for racehorse necropsy information and has recommended all horses that come off the vet's list be subject to testing.
State-by-state efforts to bring about uniformity in medication policies and drug testing aren't sufficient to move the Thoroughbred industry forward speakers said Aug. 9 at The Jockey Club Round Table conference.
Marc Summers, vice president and general counsel for The Jockey Club, has prepared a side-by-side comparison of two federal bills that propose creating a national program for managing medication use in racehorses.